Accanis Biotech
ACCANIS is developing novel, mRNA-based therapeutics for local skin diseases (non-melanoma skin cancer (NMSC including actinic keratosis, AK) and skin rejuvenation. Their mission is to pioneer mRNA-based blockbuster treatments for the skin. Lead product candidates /compounds identified and patent protected